MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN)

Historical Holders from Q1 2014 to Q3 2025

Symbol: MYGN on Nasdaq
Type / Class: Equity / Common Stock, par value $0.01 per share
Shares outstanding: 93,104,451
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 88,524,030
Holdings value: $639,914,495
% of all portfolios: 0%
Number of holders: 213
Number of buys: 111
Number of sells: -107
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
BlackRock, Inc.	15.3%		$74,900,419		14,105,009		BlackRock, Inc.	30 Jun 2025
VANGUARD GROUP INC	8.47%	-16%	$56,990,583	-$9,941,091	7,882,515	-15%	The Vanguard Group	30 Sep 2025
INTEGRATED CORE STRATEGIES (US) LLC	5.1%	-4%	$34,330,404	-$1,275,278	4,748,327	-3.6%	Millennium Management LLC	30 Sep 2025
BARCLAYS PLC	4.23%	-22%	$28,480,691	-$6,945,955	3,939,238	-20%	Barclays PLC	30 Sep 2025
Camber Capital Management LP	3.41%		$22,320,000		3,100,000		Camber Capital Management LP	31 Dec 2024
DISCIPLINED GROWTH INVESTORS INC /MN	0.8%	-86%	$4,244,772	-$19,924,683	753,956	-82%	DISCIPLINED GROWTH INVESTORS INC /MN	30 Jun 2025

Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	88,524,030	$639,914,495	+$7,199,354	$136,647	$622,603	$7.23	213
2025 Q2	90,529,530	$480,755,771	-$73,903,588	$75,402	$2,443,062	$5.31	216
2025 Q1	93,969,029	$833,362,943	+$10,158,296	$161,434	$846,198	$8.87	226
2024 Q4	92,375,178	$1,266,992,283	-$38,609,730	$283,797	$4,067,757	$13.71	215
2024 Q3	90,691,605	$2,483,201,789	-$46,730,979	$931,260	$2,741,739	$27.39	242
2024 Q2	92,267,243	$2,256,709,187	-$39,028,941	$2,773,764	$2,852,036	$24.46	222
2024 Q1	93,842,572	$2,001,184,496	+$85,643,654	$304,876	$5,973,864	$21.32	185
2023 Q4	89,898,458	$1,720,778,542	+$139,092,939	$1,046,958	$2,495,856	$19.14	193
2023 Q3	82,696,930	$1,326,499,466	+$18,782,858	$256,640	$5,686,180	$16.04	184
2023 Q2	81,069,882	$1,879,159,822	-$25,379,016	$424,194	$15,243,168	$23.18	184
2023 Q1	82,216,167	$1,909,846,418	+$45,174,636	$69,690	$15,357,461	$23.23	186
2022 Q4	80,553,035	$1,168,812,560	-$19,067,888	$40,628	$976,523	$14.51	191
2022 Q3	81,539,353	$1,555,961,809	+$26,155,420	$832,000	$2,242,000	$19.08	184
2022 Q2	79,888,231	$1,451,741,809	+$19,085,207	$887,000	$4,269,000	$18.17	185
2022 Q1	78,868,034	$1,987,215,536	+$13,382,979	$789,000	$6,986,000	$25.2	198
2021 Q4	78,283,503	$2,159,672,726	-$41,784,396	$2,732,000	$10,664,000	$27.6	191
2021 Q3	79,271,409	$2,560,639,030	+$122,124,573	$3,953,000	$7,204,000	$32.29	208
2021 Q2	75,479,842	$2,308,615,173	+$49,345,949	$2,616,000	$3,937,000	$30.58	198
2021 Q1	73,860,328	$2,248,603,947	-$35,142,715	$2,539,000	$3,739,000	$30.45	193
2020 Q4	74,996,999	$1,483,013,849	+$38,048,718	$2,837,000	$3,422,000	$19.78	176
2020 Q3	78,424,909	$1,022,586,628	+$19,999,510	$1,606,000	$1,834,000	$13.04	185
2020 Q2	72,886,989	$826,507,154	-$36,910,370	$2,441,000	$2,527,000	$11.34	188
2020 Q1	73,615,521	$1,053,548,995	-$123,804,400	$5,539,000	$2,473,000	$14.31	182
2019 Q4	78,975,742	$2,150,434,501	+$34,090,453	$12,838,000	$8,625,000	$27.23	219
2019 Q3	77,664,088	$2,224,059,833	+$28,066,291	$12,929,000	$9,939,000	$28.63	218
2019 Q2	77,043,291	$2,139,470,240	-$65,887,514	$23,094,000	$18,806,000	$27.78	231
2019 Q1	78,750,518	$2,615,130,134	+$97,424,616	$52,577,000	$21,387,000	$33.2	258
2018 Q4	76,435,291	$2,221,293,320	+$6,245,068	$5,136,000	$2,257,000	$29.07	259
2018 Q3	75,541,156	$3,474,992,493	+$111,969,670	$12,990,000	$9,449,000	$46	278
2018 Q2	73,460,919	$2,745,652,207	-$56,197,259	$5,098,000	$7,239,000	$37.37	249
2018 Q1	75,270,680	$2,223,643,624	+$16,205,290	$6,969,000	$10,668,000	$29.55	253
2017 Q4	74,845,228	$2,570,635,302	-$22,877,461	$5,237,000	$7,368,000	$34.34	245
2017 Q3	75,226,201	$2,721,461,140	-$231,871,181	$17,613,000	$9,144,000	$36.18	216
2017 Q2	82,113,528	$2,121,588,355	-$24,472,655	$13,304,000	$18,274,000	$25.84	236
2017 Q1	83,778,198	$1,608,413,977	+$174,303,798	$8,259,000	$3,930,000	$19.2	231
2016 Q4	79,796,561	$1,330,583,231	-$62,889,463	$19,055,000	$3,936,000	$16.67	217
2016 Q3	82,688,844	$1,701,064,840	-$42,443,387	$7,564,000	$4,835,000	$20.58	217
2016 Q2	81,092,174	$2,481,784,291	-$33,967,136	$24,683,000	$7,387,000	$30.6	250
2016 Q1	81,837,318	$3,063,093,588	-$304,511,458	$7,845,000	$3,512,000	$37.43	230
2015 Q4	89,677,551	$3,871,037,353	-$60,385,179	$11,073,000	$7,404,000	$43.16	229
2015 Q3	91,172,269	$3,416,315,178	-$59,259,619	$26,202,000	$26,399,000	$37.48	231
2015 Q2	92,876,142	$3,156,788,683	-$19,072,131	$14,927,000	$8,782,000	$33.99	229
2015 Q1	92,602,268	$3,277,634,496	-$49,667,719	$19,049,000	$18,292,000	$35.4	247
2014 Q4	94,137,654	$3,207,918,704	-$81,570,182	$45,161,000	$17,195,000	$34.06	265
2014 Q3	95,844,578	$3,696,576,481	-$222,241,326	$39,120,000	$31,077,000	$38.57	270
2014 Q2	102,126,793	$3,952,163,523	-$223,082,374	$113,150,000	$31,391,000	$38.92	282
2014 Q1	108,172,480	$3,703,941,847	+$239,360,362	$140,110,000	$49,717,000	$34.19	277